US 10335460
IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions
granted A61KA61K38/1793A61K38/2046
Quick answer
US patent 10335460 (IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions) held by THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Grant date
- Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/1793, A61K38/2046, A61K38/2086, A61K39/39558